Gene Therapy in Action: CTLA4 Haploinsufficiency
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
-
Gene Therapy in Action: Fabry Disease
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy In Action: Amyotrophic Lateral Sclerosis (ALS)
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy in Action: Thalassemia
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Swift, Responsive Site Support Drives Study Success
A client needed to open 50 U.S. sites for a viral vector cancer vaccine study. Finding sites with the right expertise and facilities was going…
-
Sabai Global Unifies Services, Streamlining Access to Its Comprehensive IRB and IBC Solutions
Sabai is proud to announce the consolidation of its subsidiary service lines—Castle IRB, CBS IBC and Shield Consulting—under one unified brand: Sabai Global. Now, all…
-
Tailor-Built and Thoroughly Trained: Emergency Preparedness using the BioWOPER Methodology from Sabai
Introduction As routine handlers of highly dangerous biological materials and processes, laboratories throughout the biopharmaceutical manufacturing industry are required to possess strict emergency response protocols…
-
Experience the Sabai Difference: Swift, Proactive, Reliable IRB Review
Let’s imagine for a moment: picture your ideal Institutional Review Board (IRB) experience. What would it be like? How would it impact your team and…
-
Expect More From Your IRB: Quality and Accountability in the Sabai Experience
Introduction: The No-Choice Illusion You’ve seen it, and we know it: The pharma industry’s two-organization monopoly of IRB services promises devotion to your clinical trials…
![Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])](https://sabaiglobal.com/wp-content/uploads/2024/09/sab-wp2-768x508.png)
